Leukemia/Lymphoma/Hematologic

Leukemia/Lymphoma/Hematologic

SS 35 - Hematologic 3 -?Translating Better Technology to Improved Outcome in Primary and Relapsed Disease

10/24/2018
7:45 AM - 9:00 AM
Location: Room 007 A/B

Session Type: Scientific
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits

Presentations:

Bradford Hoppe, MD, MPH

Disclosure:
Employment
University of Florida: Associate Professor: Employee

Compensation
Children Oncology Group: Travel Expenses; NRG: Research Grants; Proton Collaborative Group: Advisory Board

Leadership
American College of Radiology: Member of the Lymphoma Sub-committee; Proton Collaborative Group: Secretary, see below; RTOG: Co-Chair of RTOG 1308

Presentation(s):

Send Email for Bradford Hoppe

Chelsea Pinnix, MD, PhD

MD Anderson Cancer Center

Disclosure:
Employment
MD Anderson Cancer Center: Assistant Professor: Employee

Compensation
Global Oncology One: Consultant; Merck & Co.: Research Grants

Leadership
International Journal of Radiation Oncology, Biology and Physics: Senior Editor

Presentation(s):

Send Email for Chelsea Pinnix


Assets

SS 35 - Hematologic 3 -?Translating Better Technology to Improved Outcome in Primary and Relapsed Disease



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 35 - Hematologic 3 -?Translating Better Technology to Improved Outcome in Primary and Relapsed Disease